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Cluster headache is a severe, disabling disorder with pain
that ranks among the most severe known to humans. It is
associated with accompanying autonomic symptoms ipsi-
lateral to the pain and a sense of restlessness or agitation.
Patients with cluster headaches have few therapeutic
options, and a further 10-20% develop drug-resistant
attacks. The often brief duration of cluster attacks makes
abortive therapy a challenge, and preventive medications
are almost always provided to patients.
Although NMDA-R activation by glutamate has been
hypothesized to play a role in the pathophysiology of
primary headache disorders, its role is still not fully
understood. In fact, the trigeminovascular nociceptive
transmission from primary afferents through the trigem-
inal nucleus caudalis and on to other parts of the CNS
involves both the NMDA and non-NMDA glutamate
receptors. The kynurenine pathway (KP), accounting for
more than 90% of the tryptophan metabolism, generates
neuroactive compounds that are able to interact with
glutamate receptors both in the central and in the per-
ipheral nervous systems. Among the KP metabolites,
Kynurenic Acid (KYNA) and Quinolinic Acid (QUINA)
have been shown to interact with ionotropic glutamate
receptors. QUINA acts as an orthosteric agonist at the
GluN2 subunits of NMDA receptors and it might regu-
late endogenous glutamate release and uptake inhibition
and lipid peroxidation. In contrast, KYNA acts as a
competitive antagonist at the glycine site on the GluN1
subunit of NMDA receptors, thereby inhibiting NMDA
receptor function. KYNA also inhibits the kainate and the
amino-3-hydroxy-5-methyl-4-isoxazole propionic acid
(AMPA) glutamate receptors, and has a non-competitive
inhibitory action on the a7-nicotinic acetylcholine
receptors [1].
In this preliminary study we enrolled 14 cluster head-
ache patients (CH, 13 males) and 15 age-matched healthy
controls (HC, 14 males). We developed a HPLC tandem
mass spectrometry method to assess the serum concentra-
tions of KYNA, QUINA, Anthranilic acid and Kynurenine.
Kynurenine serum levels resulted not significantly differ-
ent between the groups (HC 0.33±0.1 and CH 0.35±0.14;
Z= -0.53, p = 0.597), while both QUINA, KYNA and
Anthranilic Acid were significantly reduced in cluster
headache patients with respect to healthy controls
(QUINA: HC 18.94±5.24 and CH 3.14±4.87; Z= -4.38,
p < 0.001; KYNA: HC 3.53±1.33 and CH 2.53±1.20;
Z= -12.45, p = 0.041; Anthranilic Acid: HC 1.28±1.14 and
CH 0.17±0.06; Z= -4.46, p < 0.001). These results highlight
that the endogenous regulation of the glutamatergic trans-
mission in cluster headache might play an important role
in its pathophysiology.
Written informed consent to publication was obtained
from the patient(s).
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